Jonathan R. Aspe

896 total citations
9 papers, 749 citations indexed

About

Jonathan R. Aspe is a scholar working on Molecular Biology, Immunology and General Health Professions. According to data from OpenAlex, Jonathan R. Aspe has authored 9 papers receiving a total of 749 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Immunology and 1 paper in General Health Professions. Recurrent topics in Jonathan R. Aspe's work include Extracellular vesicles in disease (5 papers), RNA Interference and Gene Delivery (3 papers) and Immunotherapy and Immune Responses (2 papers). Jonathan R. Aspe is often cited by papers focused on Extracellular vesicles in disease (5 papers), RNA Interference and Gene Delivery (3 papers) and Immunotherapy and Immune Responses (2 papers). Jonathan R. Aspe collaborates with scholars based in United States. Jonathan R. Aspe's co-authors include Nathan R. Wall, Jessica M.S. Jutzy, Salma Khan, Jonathan W. Neidigh, Dan Mercola, Michelle M. Lilly, Saied Mirshahidi, Malyn May Asuncion Valenzuela, David Turay and Carlos J. Díaz Osterman and has published in prestigious journals such as PLoS ONE, British Journal of Cancer and Journal of Extracellular Vesicles.

In The Last Decade

Jonathan R. Aspe

8 papers receiving 725 citations

Peers

Jonathan R. Aspe

MB

CR

IMMUN

ONCOL

BE

Jessica M.S. Jutzy United States

Sihua Qin China

Agata Abramowicz Poland

Haixin Huang China

Sudipto K. Chakrabortty United States

Marine Cordonnier France

Axl Neurauter Norway

Jena Tavormina United States

Dongyan Cao China

Olga Shatnyeva Germany

Jessica M.S. Jutzy United States

Jonathan R. Aspe

596 ×0.9

MB

389 ×0.9

CR

116 ×1.0

IMMUN

92 ×1.0

ONCOL

66 ×0.9

BE

Citations per year, relative to Jonathan R. Aspe Jonathan R. Aspe (= 1×) peers Jessica M.S. Jutzy

Countries citing papers authored by Jonathan R. Aspe

Since Specialization

Citations

This map shows the geographic impact of Jonathan R. Aspe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan R. Aspe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan R. Aspe more than expected).

Fields of papers citing papers by Jonathan R. Aspe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan R. Aspe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan R. Aspe. The network helps show where Jonathan R. Aspe may publish in the future.

Co-authorship network of co-authors of Jonathan R. Aspe

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan R. Aspe. A scholar is included among the top collaborators of Jonathan R. Aspe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan R. Aspe. Jonathan R. Aspe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Gavaza, Paul, et al.. (2018). Examining the Attitudes and Beliefs of California Pharmacists Toward Dispensing Medications Intended to be Lethal. 65(3). 14–19. 1 indexed citations

2.

Wall, Nathan R., Amber Gonda, Jessica M.S. Jutzy, et al.. (2015). Cell death in response to antimetabolites directed at ribonucleotide reductase and thymidylate synthase. OncoTargets and Therapy. 8. 495–495. 9 indexed citations

3.

Aspe, Jonathan R., et al.. (2014). Enhancement of Gemcitabine sensitivity in pancreatic adenocarcinoma by novel exosome‐mediated delivery of the Survivin‐T34A mutant. Journal of Extracellular Vesicles. 3(1). 108 indexed citations

4.

Aspe, Jonathan R., et al.. (2012). Abstract A21: Survivin-T34A enhances gemcitabine treatment in pancreatic cancer.. A21–A21. 1 indexed citations

5.

Khan, Salma, Jessica M.S. Jutzy, Malyn May Asuncion Valenzuela, et al.. (2012). Plasma-Derived Exosomal Survivin, a Plausible Biomarker for Early Detection of Prostate Cancer. PLoS ONE. 7(10). e46737–e46737. 264 indexed citations

6.

Khan, Salma, Jessica M.S. Jutzy, Jonathan R. Aspe, & Nathan R. Wall. (2012). Abstract B97: Exosomal survivin, a potential tool for early detection of pancreatic cancer health disparity?. Tumor Biology. B97–B97. 1 indexed citations

7.

Khan, Salma, et al.. (2010). Survivin is released from cancer cells via exosomes. APOPTOSIS. 16(1). 1–12. 222 indexed citations

8.

Khan, Salma, Jonathan R. Aspe, Frankis Almaguel, et al.. (2009). Extracellular, cell-permeable survivin inhibits apoptosis while promoting proliferative and metastatic potential. British Journal of Cancer. 100(7). 1073–1086. 129 indexed citations

9.

Galloway, Nicholas R., et al.. (2009). Enhanced Antitumor Effect of Combined Gemcitabine and Proton Radiation in the Treatment of Pancreatic Cancer. Pancreas. 38(7). 782–790. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact